JP6462585B2 - 医学的測定曲線の評価方法 - Google Patents

医学的測定曲線の評価方法 Download PDF

Info

Publication number
JP6462585B2
JP6462585B2 JP2015548568A JP2015548568A JP6462585B2 JP 6462585 B2 JP6462585 B2 JP 6462585B2 JP 2015548568 A JP2015548568 A JP 2015548568A JP 2015548568 A JP2015548568 A JP 2015548568A JP 6462585 B2 JP6462585 B2 JP 6462585B2
Authority
JP
Japan
Prior art keywords
measurement curve
value
curve
evaluation
optical measurement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015548568A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016505840A5 (https=
JP2016505840A (ja
Inventor
アイグナー ジーモン
アイグナー ジーモン
ケムニティウス ガブリエーレ
ケムニティウス ガブリエーレ
ホルン カリーナ
ホルン カリーナ
リムブルク ベルント
リムブルク ベルント
オッテンシュタイン ティモ
オッテンシュタイン ティモ
ペトリヒ ボルフガング
ペトリヒ ボルフガング
プルム マルクス
プルム マルクス
リンゲマン クリスティアン
リンゲマン クリスティアン
ゼーア マルクス
ゼーア マルクス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JP2016505840A publication Critical patent/JP2016505840A/ja
Publication of JP2016505840A5 publication Critical patent/JP2016505840A5/ja
Application granted granted Critical
Publication of JP6462585B2 publication Critical patent/JP6462585B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/10Signal processing, e.g. from mass spectrometry [MS] or from PCR
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/27Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
    • G01N21/274Calibration, base line adjustment, drift correction
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84Systems specially adapted for particular applications
    • G01N21/8483Investigating reagent band
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00Features of devices classified in G01N21/00
    • G01N2201/12Circuits of general importance; Signal processing
    • G01N2201/129Using chemometrical methods
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • Y10T436/144444Glucose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Databases & Information Systems (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Epidemiology (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Evolutionary Biology (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Biophysics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mathematical Physics (AREA)
  • Plasma & Fusion (AREA)
  • Signal Processing (AREA)
JP2015548568A 2012-12-20 2013-12-19 医学的測定曲線の評価方法 Active JP6462585B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12198445.4 2012-12-20
EP12198445 2012-12-20
PCT/EP2013/077348 WO2014096174A1 (en) 2012-12-20 2013-12-19 Method for evaluating medical measurement curves

Publications (3)

Publication Number Publication Date
JP2016505840A JP2016505840A (ja) 2016-02-25
JP2016505840A5 JP2016505840A5 (https=) 2017-02-09
JP6462585B2 true JP6462585B2 (ja) 2019-01-30

Family

ID=47603061

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015548568A Active JP6462585B2 (ja) 2012-12-20 2013-12-19 医学的測定曲線の評価方法

Country Status (9)

Country Link
US (2) US20150286778A1 (https=)
EP (1) EP2936124B1 (https=)
JP (1) JP6462585B2 (https=)
KR (1) KR101789893B1 (https=)
CN (1) CN104870982B (https=)
CA (1) CA2896152C (https=)
HU (1) HUE034313T2 (https=)
PL (1) PL2936124T3 (https=)
WO (1) WO2014096174A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2910360C (en) * 2013-06-10 2018-07-10 F. Hoffmann-La Roche Ag Method and system for detecting an analyte in a body fluid
GB201507458D0 (en) * 2015-04-30 2015-06-17 Inside Biometrics Ltd System and method for measuring fitness-related parameters
IT201600094056A1 (it) * 2016-09-20 2018-03-20 Bilimetrix S R L Metodo di taratura per un dispositivo di misura della bilirubina
KR20200142541A (ko) * 2018-04-06 2020-12-22 베링거잉겔하임베트메디카게엠베하 분석물의 측정 방법 및 분석 시스템
EP3640946A1 (en) * 2018-10-15 2020-04-22 Sartorius Stedim Data Analytics AB Multivariate approach for biological cell selection
PL3650843T3 (pl) * 2018-11-07 2022-05-02 F. Hoffmann-La Roche Ag Sposoby i urządzenia do wykonywania pomiaru analitycznego
CN109682968B (zh) * 2018-11-08 2022-03-11 上海艾瑞德生物科技有限公司 一种荧光免疫试条定量检测测试信号温度矫正方法
JP2021092476A (ja) * 2019-12-11 2021-06-17 清水建設株式会社 評価装置、評価方法、学習装置、及び学習方法
JP2024507652A (ja) * 2021-01-11 2024-02-21 メソ スケール テクノロジーズ エルエルシー アッセイシステムの較正システム及び方法
US11796549B2 (en) * 2021-02-12 2023-10-24 Hach Company Real-time management of analyte recovery
WO2022221884A1 (en) * 2021-04-16 2022-10-20 Beth Israel Deaconess Medical Center, Inc. Systems and methods for non-selective stimulated echo multislice diffusion imaging
KR102717386B1 (ko) * 2022-01-27 2024-10-15 스페클립스 주식회사 의료 진단 장치 및 이의 제어 방법
WO2025162776A1 (en) 2024-02-02 2025-08-07 Roche Diabetes Care Gmbh Analytical method for detecting at least one analyte in a bodily fluid
CN120257815B (zh) * 2025-03-25 2026-03-31 南京埃德伯格智能技术有限公司 一种多目标优化下的废气净化方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3826922A1 (de) 1988-08-09 1990-02-22 Boehringer Mannheim Gmbh Verfahren zur kolorimetrischen bestimmung eines analyten mittels enzymatischer oxidation
DE3940010A1 (de) 1989-12-02 1991-06-06 Boehringer Mannheim Gmbh Verwendung eines schwer loeslichen salzes einer heteropolysaeure zur bestimmung eines analyts, entsprechendes bestimmungsverfahren sowie hierfuer geeignetes mittel
DE4221807C2 (de) * 1992-07-03 1994-07-14 Boehringer Mannheim Gmbh Verfahren zur analytischen Bestimmung der Konzentration eines Bestandteiles einer medizinischen Probe
HU222809B1 (hu) 1997-10-03 2003-10-28 77 Elektronika Műszeripari Kft. Eljárás és készülék kémiai összetevőnek anyagmintából, különösen vér glükóztartalmának vérmintából történő meghatározásához
US20030036202A1 (en) * 2001-08-01 2003-02-20 Maria Teodorcyzk Methods and devices for use in analyte concentration determination assays
JP2005537891A (ja) 2002-09-10 2005-12-15 ユーロ−セルティーク エス.エイ. 血液成分の非侵襲的測定のための装置及び方法
US7118916B2 (en) * 2002-10-21 2006-10-10 Lifescan, Inc. Method of reducing analysis time of endpoint-type reaction profiles
JP4745959B2 (ja) * 2003-05-12 2011-08-10 リバー・ダイアグノスティクス・ビー.・ブイ. 微生物の自動特徴づけおよび分類
JP5065013B2 (ja) * 2004-05-14 2012-10-31 バイエル・ヘルスケア・エルエルシー グルコースアッセイにおいてヘマトクリットの調整を行う方法、およびそのための装置
ES2315950T3 (es) 2005-03-15 2009-04-01 F. Hoffmann-La Roche Ag Metodo y sistema para el analisis del metabolismo de la glucosa.
US20060281187A1 (en) * 2005-06-13 2006-12-14 Rosedale Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
DE102005035461A1 (de) 2005-07-28 2007-02-15 Roche Diagnostics Gmbh Stabile NAD/NADH-Derivate
CN101915736B (zh) * 2005-10-28 2012-06-20 松下电器产业株式会社 测定仪器、测定装置和测定方法
US20070235346A1 (en) * 2006-04-11 2007-10-11 Popovich Natasha D System and methods for providing corrected analyte concentration measurements
EP1909206A1 (de) 2006-09-11 2008-04-09 Roche Diagnostics GmbH Messbereichserweiterung chromatografischer Schnellteste
US7629125B2 (en) 2006-11-16 2009-12-08 General Electric Company Sequential analysis of biological samples
EP1985996A1 (de) 2007-04-27 2008-10-29 Roche Diagnostics GmbH Analysesystem zur photometrischen Bestimmung eines Analyten in einer Körperflüssigkeit mit einem Analysegerät und einem Testträger zur Aufnahme in das Analysegerät
ES2681895T3 (es) 2007-06-18 2018-09-17 F. Hoffmann-La Roche Ag Método y sistema de control de la glucosa para monitorizar la respuesta metabólica individual y para generar una respuesta nutricional
PL2040072T3 (pl) * 2007-09-22 2013-06-28 Hoffmann La Roche System analityczny do określania koncentracji analitu w płynie ustrojowym
MX2010006392A (es) 2007-12-10 2010-07-02 Bayer Healthcare Llc Compensacion basada en la pendiente.
EP2093284A1 (de) 2008-02-19 2009-08-26 F.Hoffmann-La Roche Ag Stabilisierung von Dehydrogenasen mit stabilen Coenzymen
CN101622541A (zh) 2008-10-24 2010-01-06 韩国帕克特生物科技有限公司 糖化血红蛋白定量检测系统及使用该系统检测糖化血红蛋白含量的方法
CA2769154C (en) 2009-07-27 2015-10-27 F. Hoffmann-La Roche Ag Method and substances for preparation of n-substituted pyridinium compounds
CN102471793B (zh) 2009-07-27 2014-04-30 霍夫曼-拉罗奇有限公司 Carba-nad的酶促合成
CN102471272B (zh) 2009-07-27 2014-09-10 霍夫曼-拉罗奇有限公司 制备n-取代吡啶鎓化合物的方法和物质
US20130189702A1 (en) * 2010-04-21 2013-07-25 Siemens Healthcare Diagnostics Inc. Curve Processor Algorithm for the Quality Control of (RT-) qPCR Curves
JP5812701B2 (ja) * 2010-06-23 2015-11-17 アークレイ株式会社 血漿グルコース測定方法
NZ609363A (en) * 2010-10-18 2015-04-24 Nestec Sa Methods for determining anti-drug antibody isotypes
EP3901624B1 (en) 2010-12-22 2024-01-31 Roche Diabetes Care GmbH Methods to compensate for sources of error during electrochemical testing
JP5801590B2 (ja) * 2011-04-11 2015-10-28 シスメックス株式会社 生体成分測定方法

Also Published As

Publication number Publication date
CA2896152C (en) 2018-07-24
EP2936124A1 (en) 2015-10-28
US20150286778A1 (en) 2015-10-08
WO2014096174A1 (en) 2014-06-26
JP2016505840A (ja) 2016-02-25
EP2936124B1 (en) 2017-03-15
US10984892B2 (en) 2021-04-20
PL2936124T3 (pl) 2017-08-31
KR20150090152A (ko) 2015-08-05
CN104870982A (zh) 2015-08-26
CN104870982B (zh) 2019-02-15
CA2896152A1 (en) 2014-06-26
US20190325992A1 (en) 2019-10-24
KR101789893B1 (ko) 2017-11-20
HUE034313T2 (en) 2018-02-28
HK1213992A1 (zh) 2016-07-15

Similar Documents

Publication Publication Date Title
JP6462585B2 (ja) 医学的測定曲線の評価方法
JP6441812B2 (ja) 体液試料を分析する方法
TWI600892B (zh) 決定樣本中待測物濃度的方法及生物感測器系統
IL144401A (en) System and method for noninvasive blood analyte measurements
CN113490843B (zh) 采用拉曼光谱确定病毒滴度的方法
CN121185982A (zh) 一种基于人工智能优化的dna定量荧光计校准系统
JP7038230B2 (ja) 細胞数を推定する方法および細胞数を推定する装置
HK1213992B (zh) 用於评估医学测量曲线的方法
HK1213637B (en) Method for analyzing a sample of a body fluid
Lin et al. Biological Materials
GB2632096A (en) A method and a device for testing a model
EP4634832A1 (en) System and method for generating a prediction model based on an input dataset
EP0762108A2 (en) Method of and apparatus for measuring ketone concentration in organism
WO2025162776A1 (en) Analytical method for detecting at least one analyte in a bodily fluid
Chen et al. Glucose and Lactate Sensing Using Raman Spectroscopy Based Upon Iterative Pls Machine Learning
Rocha¹ et al. Assessment of Performance and Uncertainty in Qualitative Analytical Chemistry: A Metrological Approach based on the Eurachem/CITAC Guide

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150625

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161216

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161216

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20171030

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180228

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180410

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180620

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180807

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181010

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20181127

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181227

R150 Certificate of patent or registration of utility model

Ref document number: 6462585

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250